Private company

Adorbs Inc

Adorbs Inc is an American medicinal chemicals and botanical products company.¹ It is headquartered in Saskatchewan, Canada.¹

Last updated Oct 21, 2026.

Overview

IndustryMedicinal Chemicals & Botanical Products¹
HeadquartersSaskatchewan, Canada¹
Incorporated inNV²
Business address36 Fourth Ave. N, Saskatchewan, A9 S3N 2V7²
Filer categoryNon-accelerated filer, Smaller reporting company²

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

76.1%Gross margin³

-114.9%Operating margin³

-115.5%Net margin³

366069.1%Revenue growth, 2022³

Where the money goes

Where each dollar of revenue went, fiscal 2022

Cost of revenueOther costs

Cost of revenue24¢$70.8K
Other costs76¢$225.8K

Out of $296.6K in revenue.³ The company lost money this year.

Financial statements

Revenue⁴⁵⁶³$296.6K in 2022+2418% since 2018

Gross profit⁴⁵⁶³$225.8K in 2022+2963% since 2018

Operating income⁴⁵⁶³-$340.9K in 2022+791% since 2018

Net income⁴⁵⁶³-$342.6K in 2022+798% since 2018

Fiscal year	2018	2019	2020	2021	2022
Revenue	$11.8K⁴	$17.9K⁵	$222⁶	$81³	$296.6K³
Cost of revenue	$4.4K⁴	$5.9K⁵	$36⁶		$70.8K³
Gross profit	$7.4K⁴	$12.0K⁵	$186⁶	$81³	$225.8K³
Research and development	$649⁴
Operating expenses				$45.9K³	$566.7K³
Operating income	-$38.3K⁴	-$22.7K⁵	-$64.7K⁶	-$45.8K³	-$340.9K³
Income before tax				-$45.8K³	-$342.6K³
Net income	-$38.2K⁴	-$22.6K⁵	-$64.6K⁶	-$45.8K³	-$342.6K³

Total assets⁴⁵⁶³$680.7K in 2022+3961% since 2017

Total liabilities⁴⁵⁶³$1.1M in 2022+4318% since 2017

Shareholders’ equity⁴⁵⁶³-$463.3K in 2022+4974% since 2017

Cash⁴⁵⁶³$41.8K in 2022+149% since 2017

Fiscal year	2017	2018	2019	2020	2021	2022
Cash	$16.8K⁴	$36.6K⁵	$19.9K⁶	$13.6K⁶	$9.5K⁶	$41.8K³
Receivables						$1.3K³
Inventory					$0³	$35.3K³
Current assets	$16.8K⁴	$64.3K⁴	$53.8K⁵	$13.6K⁶	$9.5K³	$79.6K³
Goodwill						$512.2K³
Intangible assets						$88.9K³
Total assets	$16.8K⁴	$64.3K⁴	$53.8K⁵	$13.6K⁶	$9.5K³	$680.7K³
Current liabilities	$25.9K⁴	$65.0K⁴	$77.1K⁵	$101.5K⁶	$143.2K³	$1.1M³
Total liabilities	$25.9K⁴	$65.0K⁴	$77.1K⁵	$101.5K⁶	$143.2K³	$1.1M³
Retained earnings					-$183.3K³	-$525.9K³
Shareholders’ equity	-$9.1K⁴	-$693⁵	-$23.2K⁶	-$87.9K³	-$133.7K³	-$463.3K³
Shares outstanding	3.0M shares⁴	23.9M shares⁴	23.9M shares⁵	23.9M shares⁶	23.9M shares³	75.0M shares³

Cash from operations⁴⁵⁶³-$199.2K in 2022+236% since 2018

Fiscal year	2018	2019	2020	2021	2022
Cash from operations	-$59.4K⁴	-$31.9K⁵	-$38.0K⁶	-$45.8K³	-$199.2K³
Cash from investing					$20.0K³
Cash from financing				$41.7K³	$209.7K³

Compare Adorbs Inc with another company

What it owns

What Adorbs Inc reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

Item	Latest	A year before	Change
Cash and cash equivalents	$9.5K⁶ Dec 31, 2021	$13.6K⁶ Dec 31, 2020	−30.1%

Intangibles and goodwill

Item	Latest	A year before	Change
Goodwill	$512.2K³ Dec 31, 2022
Finite-lived intangibles, net	$88.9K³ Dec 31, 2022

Inventory

Item	Latest	A year before	Change
Inventory, total	$35.3K³ Dec 31, 2022	$0³ Dec 31, 2021

Former names

Soul Biotechnology CorpMar 13, 2023 to Oct 27, 2023²
Adorbs Inc.Jan 19, 2018 to Oct 21, 2022²

Timeline

Oct 27, 20238-K Bylaws or fiscal year changed⁹
Mar 13, 20238-K Executive or director change¹⁰
May 5, 20228-K Change of auditor¹¹
Feb 10, 20228-K Entered a material agreement; Completed an acquisition or sale; Unregistered sale of shares¹²

Filings

27 filings to the SEC since October 2021: 3 annual reports, 7 quarterly reports, 4 major events, 13 other. The latest 20:

Aug 29, 2025REVOKED EDGAR
Mar 29, 2024NT 10-K EDGAR
Nov 20, 202310-Q EDGAR
Nov 13, 2023NT 10-Q EDGAR
Oct 27, 20238-K EDGAR
Oct 4, 2023DEF 14C EDGAR
Sep 27, 202310-Q EDGAR
Sep 15, 2023PRE 14C EDGAR
Aug 14, 2023NT 10-Q EDGAR
Aug 14, 2023RW EDGAR
Aug 7, 2023S-1 EDGAR
May 15, 202310-Q EDGAR
Mar 13, 20238-K EDGAR
Mar 13, 202310-K EDGAR
Oct 21, 202210-Q EDGAR
Aug 1, 202210-Q EDGAR
May 10, 202210-Q EDGAR
May 5, 20228-K EDGAR
Apr 8, 2022DEF 14C EDGAR
Mar 30, 2022PRE 14C EDGAR

The 27 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How Adorbs Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARAdorbs Inc¹
CIK0001726822
Employer ID (EIN)82-3155323¹
Filer statusNon-accelerated filer<br>smaller reporting company¹
Incorporated inNevada¹
Fiscal year endsDecember 31¹
Industry code (SIC)2833 Medicinal Chemicals & Botanical Products¹
SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
Business address36 Fourth Ave. N, Saskatchewan, A9 S3N 2V7¹
Phone(516) 544-2812¹
Shares outstanding598,545,644 as of Nov 20, 2023⁸
Public float$0 as of Jun 30, 2022³
On EDGAR sinceJan 19, 2018¹
Filings56 in all: 10-Q (13), UPLOAD (7), CORRESP (6), 8-K (5), 10-K (4), 10-12G/A (3), 10-K/A (2), DEF 14C (2)¹
All 18 form types
NT 10-K (2), NT 10-Q (2), PRE 14C (2), S-1 (2), 10-12G (1), 15-15D (1), EFFECT (1), REVOKED (1), RW (1), S-1/A (1)
Latest filingsAnnual report (10-K) Mar 13, 2023
Quarterly report (10-Q) Nov 20, 2023
Latest 8-K (8-K) Oct 27, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAdorbs Inc filings on SEC EDGAR
2
SEC EDGARAdorbs Inc filings on SEC EDGAR
3
SEC EDGARAdorbs Inc 10-K for fiscal 2022
4
SEC EDGARAdorbs Inc 10-K for fiscal 2018
5
SEC EDGARAdorbs Inc 10-K for fiscal 2019
6
SEC EDGARAdorbs Inc 10-K for fiscal 2020
7
SEC EDGARAdorbs Inc 10-Q for fiscal 2023
8
SEC EDGARAdorbs Inc 10-Q for fiscal 2023
9
SEC EDGARBylaws or fiscal year changed
10
SEC EDGARExecutive or director change
11
SEC EDGARChange of auditor
12
SEC EDGAREntered a material agreement; Completed an acquisition or sale; Unregistered sale of shares